Innoviva (INVA) Cash & Equivalents Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 61.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.17% |
| Dec 31, 2025 | 23.70% |
| Sep 30, 2025 | 16.57% |
| Jun 30, 2025 | 11.92% |
| Mar 31, 2025 | 13.75% |
| Dec 31, 2024 | 14.81% |
| Sep 30, 2024 | 24.48% |
| Jun 30, 2024 | 71.18% |
| Mar 31, 2024 | -14.25% |
| Dec 31, 2023 | -7.75% |
| Sep 30, 2023 | -27.85% |
| Jun 30, 2023 | -25.18% |
| Mar 31, 2023 | -25.76% |
| Dec 31, 2022 | 1.53% |
| Sep 30, 2022 | 20.26% |
| Jun 30, 2022 | 25.94% |
| Mar 31, 2022 | 49.30% |
| Dec 31, 2021 | 47.80% |
| Sep 30, 2021 | 40.60% |
| Jun 30, 2021 | -20.84% |
| Mar 31, 2021 | 118.45% |
| Dec 31, 2020 | 49.79% |
| Sep 30, 2020 | 51.28% |
| Jun 30, 2020 | 47.93% |
| Mar 31, 2020 | 30.11% |
| Dec 31, 2019 | 33.07% |
| Sep 30, 2019 | 22.89% |
| Jun 30, 2019 | 7.92% |
| Mar 31, 2019 | -24.57% |
| Dec 31, 2018 | -26.81% |
| Sep 30, 2018 | -14.85% |
| Jun 30, 2018 | -16.45% |
| Mar 31, 2018 | -42.29% |
| Dec 31, 2017 | -8.84% |
| Sep 30, 2017 | 5.00% |
| Jun 30, 2017 | -15.03% |
| Mar 31, 2017 | 8.45% |
| Dec 31, 2016 | -6.31% |
| Sep 30, 2016 | -18.46% |
| Jun 30, 2016 | -17.24% |
| Mar 31, 2016 | -17.07% |
| Dec 31, 2015 | 18.84% |
| Sep 30, 2015 | -11.14% |
| Jun 30, 2015 | -2.44% |
| Mar 31, 2015 | 114.48% |
| Dec 31, 2014 | 29.30% |
| Sep 30, 2014 | 23.99% |
| Jun 30, 2014 | 31.90% |
| Mar 31, 2014 | -5.38% |
| Dec 31, 2013 | -4.22% |
| Sep 30, 2013 | 39.66% |
| Jun 30, 2013 | 41.91% |
| Dec 31, 2012 | 25.89% |